by Sabine Possmann | Apr 2, 2020 | Uncategorized
Jointly organized by the H2020 projects EURE-CART (European Endeavour for Chimeric Antigen Receptor Therapies) & CARAMBA (SLAMF7-CAR T for Immunotherapy of Multiple Myeloma) 29 – 30 January 2020 Meeting Report EXECUTIVE SUMMARY On 29th and 30th January 2020, the...
by Sabine Possmann | Jan 7, 2020 | Uncategorized
With the first approvals of the CAR T cell treatments in Europe, a partial victory in the fight against hematological malignancies was achieved. However, the route from bench to bedside poses several challenges, demanding for a European-wide harmonization process....
by Sabine Possmann | Jun 24, 2019 | Uncategorized
In close collarboration between the CARAMBA partners Paul-Ehrlich-Insitiute, DRK-BSD and the University Hospital in Wuerzburg, first CARAMBA data were published on the bioRxiv platform. Genomic Analyses of SLAMF7 CAR-T Cells Manufactured by Sleeping Beauty Transposon...
by Sabine Possmann | May 6, 2019 | Uncategorized
With the aim of providing an overview of CAR-T cell treatment in myeloma, healthcare professional expectations and an introduction to some of the advantages and challenges for patients and in bringing it to market, Myeloma Patients Europe (MPE) will held a webinar on...
by Sabine Possmann | May 2, 2019 | Uncategorized
Myeloma Patients Europe held its annual General Assembly on 15-17 March 2019 in Munich, Germany. Next to training, scientific and advocacy sessions, CARAMBA coordinator Dr. Michael Hudecek presented on CAR-T cells in multiple myeloma and AL amyloidosis. Watch here the...